|
CTDSPL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63713487211226E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.06530340104882E-11 |
| Normal-vs-Stage2 |
2.19569999959646E-07 |
| Normal-vs-Stage3 |
2.13884465694036E-12 |
| Normal-vs-Stage4 |
3.39940298133001E-11 |
| Stage1-vs-Stage2 |
7.080000E-01 |
| Stage1-vs-Stage3 |
1.049420E-01 |
| Stage1-vs-Stage4 |
2.913600E-02 |
| Stage2-vs-Stage3 |
4.515200E-01 |
| Stage2-vs-Stage4 |
2.225400E-01 |
| Stage3-vs-Stage4 |
5.301200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.91668944341473E-14 |
| Normal-vs-AfricanAmerican |
3.723900E-03 |
| Normal-vs-Asian |
2.85519996534589E-09 |
| Caucasian-vs-AfricanAmerican |
9.473700E-02 |
| Caucasian-vs-Asian |
5.358800E-01 |
| AfricanAmerican-vs-Asian |
6.145800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.26000321287734E-11 |
| Normal-vs-Female |
1.77935444156674E-12 |
| Male-vs-Female |
6.356800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.9697004551349E-10 |
| Normal-vs-Age(41-60Yrs) |
5.340172748447E-13 |
| Normal-vs-Age(61-80Yrs) |
2.28479457575759E-11 |
| Normal-vs-Age(81-100Yrs) |
8.810400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.632990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.096200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.161200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.418400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.996000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.072600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.091500E-02 |
| Classical-VS-Follicular |
2.018800E-01 |
| Classical-VS-Other |
2.742000E-01 |
| Classical-VS-Normal |
6.19104767451972E-12 |
| Tall-VS-Follicular |
4.159400E-01 |
| Tall-VS-Other |
8.617000E-01 |
| Tall-VS-Normal |
3.90900001256966E-09 |
| Follicular-VS-Other |
6.108400E-01 |
| Follicular-VS-Normal |
3.50179996111422E-09 |
| Other-VS-Normal |
1.415920E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.49085213460876E-13 |
| Normal-vs-N1 |
5.14850384547572E-11 |
| N0-vs-N1 |
2.042600E-01 |
|
|
